5Kahan J S. Kahan F M, Goegelman R, el al. Thienamycin, a new beta-lacram anlibiotic: 1. Discovery. taxonomy, isolation and physical properties [J]. ,J Amibiol.1979.32(1 ):1.
6Kahan F M, Kropp H, Sundelof J G, et al. Thienamycin: Development of imipenem-cilastatin [J]. J Antimicrob Chemother, 1983,12 (Suppl D) : 1.
7Peterson P J, Jacobus N V, Weiss W J, et al. In vitro and in vivo activities of LJC 10.627, a new carbapenem with stability to dehydropeptidase [J]. Antimicrob Agents Chemother, 1991,35(1 ) :203.
8Jacoby G, Han P, Tran J. Comparative in vitro activities of carbapenem L-749,345 and other antimicrobials against multirisistant Gram-negative clinical pathogens [J]. Antimicrob Agents Chemother, 1997,41 (8) : 1830.
9Fuchs P C, Barry A L, Brown S D. et al. In vitro activities of ertapenem (MK-0826) against clinical bacterial isolates from 11 north American medical centers [J]. Antirnicrob Agents Cherm~ther, 2001,45 ( 6 ) : 1915.
10Rosen H, Hajdu R, Silver 1., et al. Reduced immunotoxicity and preservation of anlibacterial activity in a releasable side-chain carbapenem antibiotic [J]. Science. 1999.283:70.3.
5Kahan J S. Kahan F M, Goegelman R, el al. Thienamycin, a new beta-lacram anlibiotic: 1. Discovery. taxonomy, isolation and physical properties [J]. ,J Amibiol.1979.32(1 ):1.
6Kahan F M, Kropp H, Sundelof J G, et al. Thienamycin: Development of imipenem-cilastatin [J]. J Antimicrob Chemother, 1983,12 (Suppl D) : 1.
7Peterson P J, Jacobus N V, Weiss W J, et al. In vitro and in vivo activities of LJC 10.627, a new carbapenem with stability to dehydropeptidase [J]. Antimicrob Agents Chemother, 1991,35(1 ) :203.
8Jacoby G, Han P, Tran J. Comparative in vitro activities of carbapenem L-749,345 and other antimicrobials against multirisistant Gram-negative clinical pathogens [J]. Antimicrob Agents Chemother, 1997,41 (8) : 1830.
9Fuchs P C, Barry A L, Brown S D. et al. In vitro activities of ertapenem (MK-0826) against clinical bacterial isolates from 11 north American medical centers [J]. Antirnicrob Agents Cherm~ther, 2001,45 ( 6 ) : 1915.
10Rosen H, Hajdu R, Silver 1., et al. Reduced immunotoxicity and preservation of anlibacterial activity in a releasable side-chain carbapenem antibiotic [J]. Science. 1999.283:70.3.
